Overview


According to FutureWise analysis the market for acne therapeutics is expected to reach US$ 12.12 billion by 2031 at a CAGR of 4.80%.

Acne is a skin related disorder caused by inflammation of skin glands and hair follicles. It is common in teenagers and young adults. Acne vulgaris substantially impacts a patient's quality of life, affecting both self-esteem and psychosocial development. Patients and physicians are presented with numerous over-the-counter and prescription acne treatments, which can make selecting the most efficient therapy a daunting task. Different variants of acne exist, including acne conglobate, There are various types of acne, including acne fulminans, acne mechanica, excoriated acne, chloracne, drug-induced acne, neonatal and infantile acne, and occupational acne. Although they may look similar to acne vulgaris, they can be differentiated by their clinical setting, severity, and associated symptoms.

The goal of treating acne vulgaris is to decrease and manage current acne breakouts, prevent long-term scarring as much as possible, shorten the duration of the condition, and minimize any negative effects. The patient should be informed of the aims of preventing new acne lesions while allowing the existing ones to heal. Patients should also be aware that it may take 3–6 weeks to observe an improvement. When deciding on a treatment plan for acne, it's important to consider the patient's individual factors. These can include their current medical condition, disease history, severity of their acne, hormone levels, and their preferred treatment method. Treatment can involve using topical or oral medications, natural products, or non-drug options like optical therapy. Often, a combination of treatments that target multiple causes of acne is the most effective. The patient's progress is monitored, and the treatment plan can be adjusted as needed based on their response.

FutureWise Market Research has published a report that provides an insightful acne therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, acne therapeutics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Allergan plc
  • GlaxoSmithKline plc
  • Janssen Biotech, Inc.
  • Novartis AG
  • Amgen, Inc.
  • Celgene Corporation
  • Pfizer, Inc.
  • LEO Pharma A/S
  • Eli Lilly and Company
  • Bausch Health Companies, Inc.
  • Sun Pharmaceuticals Ltd.
  • Aclaris Therapeutics, Inc.
  • Aurobindo Pharma Ltd.
  • Johnson and Johnson
  • Nestle SA (Galderma)
  • F. Hoffmann-la Roche Ltd
  • Ranbaxy (Sun Pharmaceuticals)

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Acne Therapeutics Market:

  • In January 2022- Galderma Launched TWYNEO Cream which is commercially available in spring in the United States to treat facial acne at the American Academy of Dermatology Annual Meeting.

  • In January 2022- Journey Medical Corporation acquired two Food and Drug Administration-approved topical minocycline products and the molecule Stabilizing Technology (MST) Franchise from VYNE Therapeutics, Inc. This franchise includes AMZEEQ for the treatment of acne.

The demand for electric device-based therapies like lasers is anticipated to increase the market's growth. It also gives patients desirable and quicker treatment with effective results. Laser treatment eliminates problems permanently and reduces the likelihood of developing new ones, such as more facial hair growth and pigmentation disorders. Additionally, these treatments are less painful than other types, which makes it simpler for patients to adapt. Furthermore, the adverse effects of acne treatments vary depending on the procedure's selection and the medications. The most common side effects of topical acne medicines are skin irritation and dryness. The possible complication of oral drugs can be more severe. Antibiotics can upset the stomach or cause patients to be light-headed and dizzy. Moreover, oral isotretinoin can cause extreme side effects, mainly if the person is pregnant. Severe congenital disabilities have been noted in infants whose moms took isotretinoin during the pregnancy period. The drug can also boost the chance of suicidal thoughts and depression and impact liver functioning and cholesterol levels. The safety concerns about acne treatment products are anticipated to hinder market development. Moreover, rising awareness of current and new acne treatments poses an excellent opportunity for the market. Worldwide, the need for minimally invasive cosmetic treatment techniques is growing enormously. Dermatologists treat skin issues using less invasive or topical procedures instead of surgical procedures. More knowledge about the process, well-documented policies, and better patient-doctor relationships are boosting the need for treatments for face and skin-related issues, which has been pushing the use of less painful aesthetic combination therapy techniques.

By Product Type

  • Drug Therapy
    • Antibiotic Drugs
    • Anti-inflammatory Drugs
    • Hormonal Drugs
    • Others (Retinoid, Isotretinoin, Steroids, Chemical Peels, Etc.)
  • Laser Therapy

By Route of Administration

  • Oral
  • Topical
  • Parenteral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This can be attributed to the high prevalence of acne and skin disorders, product launches, and technological advancements in this region. Owing to the increasing awareness among the people and the presence of significant market players. The growing burden of acne in the region and recent product launches are also crucial driving factors for the growth of the acne therapeutics market in North America.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Acne Therapeutics Market By Product Type, By Route of Administration, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acne Therapeutics Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acne Therapeutics Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acne Therapeutics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acne Therapeutics Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drug Therapy
         1.1. Antibiotic Drugs
         1.2. Anti-inflammatory Drugs
         1.3. Hormonal Drugs
         1.4. Others (Retinoid, Isotretinoin, Steroids, Chemical Peels, Etc.)
        2. Laser Therapy

  • 8.   Acne Therapeutics Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Topical
        3. Parenteral

  • 9.   Acne Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 10.   North America Acne Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Acne Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Acne Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Acne Therapeutics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Allergan plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GlaxoSmithKline plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Janssen Biotech, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Amgen, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Celgene Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Pfizer, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. LEO Pharma A/S
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Eli Lilly and Company
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Bausch Health Companies, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Sun Pharmaceuticals Ltd.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Aclaris Therapeutics, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Aurobindo Pharma Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Johnson and Johnson
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Nestle SA (Galderma)
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. F. Hoffmann-la Roche Ltd
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Ranbaxy (Sun Pharmaceuticals)
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Moderate-to-Severe Acne Therapeutics Market

Read More

Acne Medication Market

Read More
Partner

Our Clients